Newsletter | September 2, 2026

09.02.26 -- Optimizing Lyophilization Through Better Process Understanding

Lyophilization Process Development For Antibody Drug Conjugates

Discover how process development and QbD principles enhance freeze-drying performance, improve product stability, and support successful biologics scale-up.

 

Factors To Consider While Selecting Stoppers For Lyophilized Vials

Container-closure selection can significantly impact the stability, integrity, and shelf life of lyophilized products. Explore available stopper options and the factors to consider when choosing the best fit for your application.

 

Best Practices In Formulation And Lyophilization Development: Proteins, mAbs And ADCs

As the science behind pharmaceutical freeze-drying advances, explore how the process continues to evolve, driven by an improved understanding of product characteristics, precise control over process conditions, and innovations in equipment efficiency.

 

The Effect Of Conventional Cooling Versus Controlled Ice Nucleation On Primary Drying Time

See how controlled ice nucleation shortens lyophilization cycles, supports higher drying temperatures, and reduces complexity for amorphous and mixed formulations without sacrificing quality.

 

Effect Of Shelf Cooling Rate On The Nucleation Temperature Of Ice Monitored Using Thermocouples And Wireless Temperature Sensors

Freezing conditions shape ice structure, mass transfer resistance, and drying efficiency. Data shows how cooling rate, vial size, and nucleation interact to optimize freeze-drying.

 

SOLUTIONS

From Lab Through Launch

An integrated path from formulation to commercial supply reduces risk, preserves product knowledge, and accelerates timelines — supported by sterile injectables expertise and reliable global capacity.

• Request Information